Drug Shortage Report for PRO-MIRTAZAPINE
Report ID | 14341 |
Drug Identification Number | 02312778 |
Brand name | PRO-MIRTAZAPINE |
Common or Proper name | MIRTAZAPINE |
Company Name | PRO DOC LIMITEE |
Market Status | MARKETED |
Active Ingredient(s) | MIRTAZAPINE |
Strength(s) | 15MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 100 |
ATC code | N06AX |
ATC description | ANTIDEPRESSANTS |
Reason for shortage | Delay in shipping of the drug. |
Anticipated start date | |
Actual start date | 2017-07-12 |
Estimated end date | |
Actual end date | 2018-11-20 |
Shortage status | Resolved |
Updated date | 2018-11-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 2925 BOULEVARD INDUSTRIEL LAVAL, QUEBEC CANADA H7L 3W9 |
Company contact information | 2925 BOULEVARD INDUSTRIEL, LAVAL QC, H7L 3W9 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v21 | 2018-11-20 | English | Compare |
v22 | 2018-11-20 | French | Compare |
v23 | 2018-11-21 | English | Compare |